Jaguar8 commented on a stock · Nov 25, 2024 21:22

NEWS

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Stereotaxis (NYSE: STXS) and MicroPort EP announced that China's National Medical Products Administration (NMPA) has approved the Genesis RMN® System. This approval enables the commercialization of advanced robotic technology for minimally-invasive procedures in China. MicroPort EP will lead the commercial launch through its existing electrophysiology sales teams. The approval is part of a broader collaboration between both companies, announced in August 2021, which includes development and integration of robotic systems, navigated catheters, and MicroPort EP's Columbus™ 3D mapping system. The Genesis system, already FDA-cleared and CE-marked, has been used to treat thousands of patients in the US and Europe.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

6066 Views

Comment

Jaguar8

Spread kindness and love. Life is short. Don’t let greed eat you.

8196

Followers

Following

93K

Visitors